Kyowa Kirin gets some added love from the FDA, winning their second drug OK in 4 months
This is a good year for Kyowa Kirin.
The company touts itself as a Japanese-based drug group with a global focus, and they got a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
